欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1360/001
药品名称Pramipexol Teva Pharma
活性成分
    • PRAMIPEXOLE DIHYDROCHLORIDE monohydrate 0.26 mg
剂型Prolonged-release tablet
上市许可持有人Teva Sweden AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Pramipexol Teva 0,26 mg tabletten met verlengde afgifte
    • Netherlands (NL)
      Pramipexol retard Teva 0,26 mg, tabletten met verlengde afgifte
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Pramipexol ratiopharm 0,26 mg Retardtabletten
    • Hungary (HU)
      PRAMIPEXOL TEVA 0,26 mg retard tabletta
    • Slovakia (SK)
      Pramipexol Teva Pharma 0,26 mg
    • Croatia (HR)
      Pramipeksol Pliva 0,26 mg tablete s produljenim oslobađanjem
许可日期2014/12/01
最近更新日期2022/09/21
药物ATC编码
    • N04BC05 pramipexole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase